Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM(2020) Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy Mol Ther(in press) DOI 10.1016/j.ymthe.2020.11.019, PubMed 33212301
Sonnet F, Namork E, Stylianou E, Gaare-Olstad I, Huse K, Andorf S, Mjaaland S, Dirven H, Nygaard U(2020) Reduced polyfunctional T cells and increased cellular activation markers in adult allergy patients reporting adverse reactions to food BMC Immunol, 21(1), 43 DOI 10.1186/s12865-020-00373-w, PubMed 32698761
Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H(2020) Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series Blood Adv, 4(9), 1859-1866 DOI 10.1182/bloodadvances.2019001325, PubMed 32374878